Problem statement: Answer the multiple choice question.
Query: Which drug has a -39.062% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CC(=O)c1c(C)[nH]c(C(=O)Nc2nc(-c3ccccc3)c(C)s2)c1C
b.) COC(=O)C(C)Sc1nc2ccsc2c(=O)n1Cc1ccccc1
Answer: b. COC(=O)C(C)Sc1nc2ccsc2c(=O)n1Cc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)C(C)Sc1nc2ccsc2c(=O)n1Cc1ccccc1
COC(=O)C(C)Sc1nc2ccsc2c(=O)n1Cc1ccccc1
methyl2-(3-benzyl-4-oxothieno[3,2-d]pyrimidin-2-yl)sulfanylpropanoate